DDIT4L and melanoma: The results were validated by bisulfite sequencing of COL1A2, NPM2, HSPB6, DDIT4L, and MT1G promoters, which exhibited increasing incidence with advanced melanoma stage, suggesting potential use as predictors of melanoma progression [39].